Published in Blood Transfus on July 01, 2010
Prevalence of hemoglobin S trait among blood donors: a cross-sectional study. BMC Res Notes (2015) 0.96
Transfusion associated peak in hb HPLC chromatogram - a case report. Mediterr J Hematol Infect Dis (2012) 0.83
Do we need to test blood donors for sickle cell anaemia? Blood Transfus (2010) 0.78
Oxidative stress in sickle cell disease. Rev Bras Hematol Hemoter (2013) 0.77
Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Trait among Prospective Blood Donors: A Cross-Sectional Study in Berekum, Ghana. Adv Hematol (2016) 0.75
Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review. Am J Epidemiol (2000) 3.17
Complications associated with sickle cell trait: a brief narrative review. Am J Med (2009) 2.42
Sickle cell disease; a general overview. Neth J Med (2004) 1.26
Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe. Haematologica (2007) 1.17
Blood transfusion-acquired hemoglobin C. Arch Pathol Lab Med (1999) 1.11
Blood transfusions leading to apparent hemoglobin C, S, and O-Arab hemoglobinopathies. Arch Pathol Lab Med (2006) 1.04
Hemoglobin C acquired via a blood transfusion. Detection by automated blood counter. Arch Pathol Lab Med (1987) 0.94
Frequency and type of newly diagnosed haemoglobin variants in Northern Italy. Blood Transfus (2010) 0.92
Hospitalization of children with sickle cell disease in a region with increasing immigration rates. Haematologica (2008) 0.91
Hematological findings in 375 Sicilians with Hb S trait. Haematologica (1990) 0.91
[An acquired S hemoglobin in the adult]. Nouv Presse Med (1974) 0.89
Spurious haemoglobinopathy. Lancet (1986) 0.87
Unexpected hemoglobin electrophoresis results following red cell exchange in a sickle cell anemia patient with acute chest syndrome. Transfus Sci (1997) 0.87
Good practice guidelines for laboratory investigation of hemoglobinopathies. Lab Hematol (2003) 0.85
[Systematic screening of hemoglobinopathies in blood donors in Guadeloupe (French West Indies)]. Rev Fr Transfus Immunohematol (1978) 0.81
Factitious sickle-cell trait. N Engl J Med (1982) 0.80
NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring) (2008) 2.23
Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres. Blood Transfus (2009) 1.62
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers. J Thromb Haemost (2012) 1.57
How I treat rare venous thromboses. Blood (2008) 1.56
Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica (2002) 1.54
Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone (2006) 1.50
Quality and reliability of routine coagulation testing: can we trust that sample? Blood Coagul Fibrinolysis (2006) 1.50
Effects on health of air pollution: a narrative review. Intern Emerg Med (2015) 1.48
The syndrome of the "obsessive-compulsory scientist": a new mental disorder? Clin Chem Lab Med (2013) 1.47
Together we care: new challenges for global haemophilia treatment centers. Indian J Med Res (2009) 1.44
Routine coagulation tests in newborn and young infants. J Thromb Thrombolysis (2007) 1.42
Recombinant human erythropoietin facilitates autologous blood collections in children undergoing corrective spinal surgery. Transfusion (2004) 1.42
Phlebotomy issues and quality improvement in results of laboratory testing. Clin Lab (2006) 1.41
Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost (2009) 1.39
The growing impact of publications in haemostasis and thrombosis journals. Thromb Haemost (2007) 1.38
The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta (2008) 1.33
The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis (2010) 1.24
Prophylaxis in people with haemophilia. Thromb Haemost (2009) 1.19
Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes. Clin Chem Lab Med (2009) 1.19
Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol (2011) 1.15
Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost (2012) 1.15
Haemorrhage and amyloidosis. Br J Haematol (2012) 1.14
Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol (2008) 1.12
Increased mean platelet volume in patients with acute coronary syndromes. Arch Pathol Lab Med (2009) 1.11
Doping in competition or doping in sport? Br Med Bull (2008) 1.11
Influence of a light meal on routine haematological tests. Blood Transfus (2010) 1.10
Imatinib and regression of type 2 diabetes. N Engl J Med (2005) 1.09
The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med (2010) 1.06
Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox". Semin Thromb Hemost (2010) 1.05
A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/ Humate -P: history and clinical performance. Eur J Haematol Suppl (2008) 1.04
Biochemistry, physiology, and complications of blood doping: facts and speculation. Crit Rev Clin Lab Sci (2006) 1.03
How to write a scientific manuscript for publication. Blood Transfus (2012) 1.02
Help me, Doctor! My D-dimer is raised. Ann Med (2008) 1.01
Mesenchymal stem cells: from biology to clinical use. Blood Transfus (2007) 1.00
Thrombotic complications of erythropoiesis-stimulating agents. Semin Thromb Hemost (2010) 1.00
Influenza and cardiovascular disease: does swine-origin, 2009 H1N1 flu virus represent a risk factor, an acute trigger, or both? Semin Thromb Hemost (2010) 0.99
Identification of spurious hemolysis in anticoagulated blood with Sysmex XE-2100 and Siemens Advia 2120. Clin Lab (2012) 0.98
Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients. Haematologica (2007) 0.97
Platelet gel in the treatment of cutaneous ulcers: the experience of the Immunohaematology and Transfusion Centre of Parma. Blood Transfus (2010) 0.96
Stability of blood cell counts, hematologic parameters and reticulocytes indexes on the Advia A120 hematologic analyzer. J Lab Clin Med (2005) 0.96
Determinants of anaemia in the very elderly: a major contribution from impaired renal function? Blood Transfus (2010) 0.96
Diagnosis and management of ischemic heart disease. Semin Thromb Hemost (2013) 0.94
Evidence-based recommendations on the treatment of von Willebrand disease in Italy. Blood Transfus (2009) 0.94
Old and new anticoagulant drugs: a minireview. Ann Med (2011) 0.94
Inherited and acquired factor V deficiency. Blood Coagul Fibrinolysis (2011) 0.94
Long-term persistence of molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia. Blood Transfus (2011) 0.94
Hemostasis, cancer, and ABO blood group: the most recent evidence of association. J Thromb Thrombolysis (2014) 0.94
Shortened activated partial thromboplastin time: causes and management. Blood Coagul Fibrinolysis (2010) 0.93
Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future. J Thromb Thrombolysis (2010) 0.93
Frequency and type of newly diagnosed haemoglobin variants in Northern Italy. Blood Transfus (2010) 0.92
TCF2 gene mutation leads to nephro-urological defects of unequal severity: an open question. Med Sci Monit (2008) 0.92
Thromboembolism in childhood nephrotic syndrome: a rare but serious complication. Hematology (2007) 0.92
Non-O blood group: an important genetic risk factor for venous thromboembolism. Blood Transfus (2012) 0.91
Effectiveness of low-dose oral calcium carbonate for the prevention of citrate-related toxicity in peripheral blood stem cell collection. Blood Transfus (2011) 0.91
Expression of CD27 and CD23 on peripheral blood B lymphocytes in humans of different ages. Blood Transfus (2009) 0.91
Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls. Clin Chem Lab Med (2004) 0.90
Acquired inhibitors of coagulation factors: part I-acquired hemophilia A. Semin Thromb Hemost (2012) 0.90
Acquired haemophilia A as a blood transfusion emergency. Blood Transfus (2008) 0.90
Intensive blood transfusion support in acquired hemophilia A. Ann Hematol (2006) 0.90
Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications. Clin Chem Lab Med (2009) 0.89
Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potency. Cancer Treat Rev (2007) 0.89
Prophylaxis in children with hemophilia: evidence-based achievements, old and new challenges. Semin Thromb Hemost (2012) 0.89
Classic thrombophilic gene variants. Thromb Haemost (2015) 0.89
Plasma PAI-1 levels are increased in patients with nonalcoholic steatohepatitis. Diabetes Care (2007) 0.88
Bleeding and thrombosis in multiple myeloma and related plasma cell disorders. Semin Thromb Hemost (2011) 0.88
Experience of secondary prophylaxis in 20 adolescent and adult Italian hemophiliacs. Thromb Haemost (2006) 0.87
Blood doping by cobalt. Should we measure cobalt in athletes? J Occup Med Toxicol (2006) 0.87
C-reactive protein and venous thromboembolism: causal or casual association? Clin Chem Lab Med (2010) 0.87
ABO blood group and von Willebrand factor: biological implications. Clin Chem Lab Med (2014) 0.87
Epidemiological association between fasting plasma glucose and shortened APTT. Clin Biochem (2008) 0.87
New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy. Pharmacotherapy (2008) 0.87
Thrombocytopenias: a clinical point of view. Blood Transfus (2009) 0.86
Lipaemic donations: truth and consequences. Transfus Apher Sci (2012) 0.86
Preventing postsurgical venous thromboembolism: pharmacological approaches. Semin Thromb Hemost (2011) 0.85
Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease not requiring chronic dialysis. Clin Chem Lab Med (2009) 0.85
Prophylaxis for adults with haemophilia: towards a personalised approach? Blood Transfus (2012) 0.85
Relationship between ABO blood group and hemorrhage: a systematic literature review and meta-analysis. Semin Thromb Hemost (2013) 0.85
Diagnostic approach to inherited bleeding disorders. Clin Chem Lab Med (2007) 0.85
Coagulation testing in pediatric patients: the young are not just miniature adults. Semin Thromb Hemost (2007) 0.85
Vaccination, squalene and anti-squalene antibodies: facts or fiction? Eur J Intern Med (2009) 0.85
Changes of human B and B-1a peripheral blood lymphocytes with age. Hematology (2007) 0.85
Inherited disorders of blood coagulation. Ann Med (2011) 0.85
Alcohol dosing and the heart: updating clinical evidence. Semin Thromb Hemost (2011) 0.84
Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities. Semin Thromb Hemost (2013) 0.84
The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement. Clin Chim Acta (2007) 0.84
Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy. Biomark Med (2011) 0.84
Pathophysiology, clinics and diagnostics of non-thrombotic pulmonary embolism. J Thromb Thrombolysis (2011) 0.84
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. Transfus Med (2011) 0.84
Solvent/detergent plasma: pharmaceutical characteristics and clinical experience. J Thromb Thrombolysis (2015) 0.83
Biochemical correlates of lipoprotein(a) in a general adult population. Possible implications for cardiovascular risk assessment. J Thromb Thrombolysis (2007) 0.83
Occult hepatitis B in blood donors: a description of two cases. Blood Transfus (2010) 0.83
Eosinophilia and first-line coagulation testing. J Thromb Thrombolysis (2008) 0.83
Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients. J Thromb Thrombolysis (2008) 0.83
One-stage clotting versus chromogenic assays for assessing recombinant factor VIII: two faces of a haemostasis coin. Blood Coagul Fibrinolysis (2009) 0.83
Dark chocolate: consumption for pleasure or therapy? J Thromb Thrombolysis (2008) 0.82
Hemostatic disorders in type 1 diabetes mellitus. Semin Thromb Hemost (2011) 0.82
Is serum Cystatin-C a suitable marker of renal function in children? Ann Clin Lab Sci (2007) 0.82
Holiday thrombosis. Semin Thromb Hemost (2011) 0.82
Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy. Blood Transfus (2010) 0.82